CAR-T(CAR-T)细胞疗法在非肿瘤性疾病中的应用
Chimeric antigen receptor T (CAR-T) cell therapy in non-oncological diseases.
CAR-T(CAR-T)细胞在血液系统恶性肿瘤中的应用推动了这种免疫治疗形式的显著进展。
CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
英文原题:Detection and quantification of integrated vector copy number by multiplex droplet digital PCR in dual-transduced CAR T cells.
Detection and quantification of integrated vector copy number by multiplex droplet digital PCR in dual-transduced CAR T cells.
分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。
针对难治性血液系统恶性肿瘤的嵌合抗原受体(CAR)T 细胞疗法取得成功后,研究者开始探索其治疗实体瘤的疗效。AUTO6NG 是一种双重转导、靶向 GD2 的 CAR,编码了为增强复发/难治性神经母细胞瘤中 T 细胞活性而设计的不同功能模块。检测并精确量化每种整合载体的载体拷贝数(VCN),对于评估各模块对 T 细胞肿瘤浸润、持久性和临床活性的影响至关重要。微滴式数字 PCR(ddPCR)可对特定核酸序列进行准确、灵敏且绝对的定量。与标准的双靶标检测相比,多重 ddPCR 检测可通过选择性调节信号幅度,同时检测最多 4 个靶标,并保留靶标定量能力。研究人员基于双通道系统开发了一种多重检测方法,可同时检测和定量 AUTO6NG CAR-T 细胞中的 3 个靶标。该检测具有高度特异性和灵敏度,准确、可靠,并且在不同时间和样本间重复性良好。标准双重检测与多重检测在 VCN 测量方面未见差异。
结果表明,ddPCR 是一种准确且具有成本效益的方法,可同时检测工程化 CAR-T 细胞基因组 DNA 中的多个靶标。
The success of chimeric antigen receptor (CAR) T cell therapies in refractory hematologic malignancies has prompted investigation of their efficacy in solid tumors. AUTO6NG is a dual-transduced GD2-targeting CAR that encodes distinct modules designed to enhance T cell activity in relapsed/refractory neuroblastoma. The ability to detect and precisely quantify vector copy number (VCN) for each integrated vector is essential for assessing the effect of each module on T cell tumor infiltration, persistence, and clinical activity.
Droplet digital PCR (ddPCR) enables accurate, sensitive, and absolute quantification of specific nucleic acid sequences. Compared to standard detection of two targets, multiplex ddPCR assays allow simultaneous detection of up to four targets by selective modulation of signal amplitude while retaining the ability to quantify the target.
We have developed a multiplex assay based on the two-channel system for simultaneous detection and quantification of three targets in AUTO6NG CAR T cells. The assay was highly specific, sensitive, accurate, and reproducible across time and samples. No differences were observed in measuring VCN between standard duplex and multiplex assays.
Our results demonstrate that ddPCR is an accurate and cost-effective method for simultaneous detection of multiple targets in genomic DNA derived from engineered CAR T cells.
在 PubMed 查看 → 出版商原文(DOI) 全文 PDF(PMC)· 可下载 治疗专题与资料阅读指南 资料来源与翻译说明 报告译文或资料问题 →
MEMBER ACCOUNT
登录成功会直接打开下一页。